Table 2

Model input parameters: costs and utilities

CostsSC £POCT £NotesReference
 Asymptomatic testing*79.7775.50SC based on current costs, POCT average of two clinic pathways (£77.42 and £73.57)Adams et al20
 Symptomatic testing*99.3892.43SC based on current costs, POCT average of two clinic pathways (£100.39 and £84.46)
 Chlamydia management, primary34.8934.89Adams et al20
 Chlamydia management, additional24.9924.99Adams et al20
 Gonorrhoea management, primary112.05117.94Includes the first treatment (primary) and a test of cure (primary)Adams et al20
 Gonorrhoea management, additional101.86107.75Includes the first treatment (additional) and a test of cure (primary)Adams et al20
 Gonorrhoea management, second line41.0741.07Second line treatment is cefixime plus azithromycinAdams et al20
BASHH2
 Treatment for PID163.00163.00Weighted average of treatment in general practice, GUM and other settingsAghaizu et al21
 Chlamydia/gonorrhoea testing*45.3438.76Reduced pathway used for partner testing onlyAdams et al20
Utilities
 Pretest status unknown1.00Assume otherwise healthy populationAssumption
 Post-test status unknown1.00Assume no anxiety while waiting for resultAssumption
 Symptomatic0.84Average for men/women for chlamydia/gonorrhoeaInstitute of Medicine22
 Infection positive0.85Assumed to be slightly decreased due to anxiety from being positiveAssumption
 Complications0.80Mean of values for PIDSmith et al23
 Infection negative1.00Assume otherwise healthy populationAssumption
  • *All testing pathways include an acquisition cost of test and sample collection kit: standard care costs £12 for the test plus £1.35 for the sample collection kit; POC costs £18 for the test plus £1.71 for the sample collection kit.

  • GUM, genitourinary medicine; PID, pelvic inflammatory disease; POCT, point of care test; SC, standard care.